ScholarIQanswers from OpenAlex

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

PaperCitations, authors & open-access status

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer have?

ScholarIQcitation count

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer has 108 citations in the OpenAlex counts ScholarIQ stores.

When was Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer published?

ScholarIQyear

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer has 2009 year in the ScholarIQ index.

What is the open-access status of Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer?

ScholarIQoa status

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer has green oa status in the ScholarIQ index.

What is the DOI of Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer?

ScholarIQdoi

The DOI for Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer is on the source record.

What is the PMID of Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer?

ScholarIQpmid

The PMID for Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer is on the source record.

What is the OpenAlex record for Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer?

ScholarIQopenalex

The OpenAlex for Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial